FDA Approves New Pancreatic Cancer Treatment

U.S. health officials approved a new drug for pancreatic cancer. The Food and Drug Administration (FDA) announced the approval, which introduces a different method for treating the illness.

The drug functions by blocking a protein that contributes to tumor growth. This protein is present in most pancreatic cancer cases. The new treatment targets this specific mechanism.